Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B R Binder

Showing results (111-120 of 219) with videos related to

Pageof 22
Sort By:
Thrombosis and Haemostasis|June 30, 1986
Monoclonal antibodies against human high molecular weight urinary urokinase: application for affinity purification of urinary prourokinaseJ Wojta, J C Kirchheimer, L Turcu, et al.
Cancer Research|April 1, 1992
Determination of plasma urokinase-type plasminogen activator antigen in patients with primary liver cancer: characterization as tumor-associated antigen and comparison with alpha-fetoproteinK Huber, J C Kirchheimer, D Ermler, et al.
Carcinogenesis|November 1, 1988
Mitogenic effect of urokinase on malignant and unaffected adjacent human renal cellsJ C Kirchheimer, J Wojta, G Christ, et al.
Obstetrics and Gynecology|August 1, 1988
Increased plasma levels of urokinase-type plasminogen activator with endometrial and cervical cancerH Koelbl, J C Kirchheimer, G Tatra, et al.
Blood|November 15, 1996
Human fibroblasts downregulate plasminogen activator inhibitor type-1 in cultured human macrovascular and microvascular endothelial cellsJ C Zhang, A Fabry, L Paucz, et al.
The Journal of Biological Chemistry|February 5, 1991
Fibronectin decreases the stimulatory effect of fibrin and fibrinogen fragment FCB-2 on plasmin formation by tissue plasminogen activatorR Beckmann, M Geiger, C de Vries, et al.
Invasion & Metastasis|January 1, 1985
Plasminogen activator activity in bone metastases of prostatic carcinomas as compared to primary tumorsJ C Kirchheimer, H Pflüger, P Ritschl, et al.
Zeitschrift Fur Kardiologie|January 1, 1993
The role of type-1 plasminogen activator inhibitor in failure of thrombolytic therapy with recombinant tissue plasminogen activatorK Huber, R Beckmann, F Rauscha, et al.
Thrombosis Research|July 15, 1996
The ACE-inhibitor lisinopril affects plasma insulin levels but not fibrinolytic parametersM Zehetgruber, R Beckmann, H Gabriel, et al.
Thrombosis Research|June 1, 1992
Modulation of heparin cofactor II activity by glycosaminoglycans and adhesive glycoproteinsE Petzelbauer, D Seiffert, R Beckmann, et al.
Pageof 22

Showing results (111-120 of 219) with videos related to

Sort By:
Pageof 22
Thrombosis and Haemostasis|June 30, 1986
Monoclonal antibodies against human high molecular weight urinary urokinase: application for affinity purification of urinary prourokinaseJ Wojta, J C Kirchheimer, L Turcu, et al.
Cancer Research|April 1, 1992
Determination of plasma urokinase-type plasminogen activator antigen in patients with primary liver cancer: characterization as tumor-associated antigen and comparison with alpha-fetoproteinK Huber, J C Kirchheimer, D Ermler, et al.
Carcinogenesis|November 1, 1988
Mitogenic effect of urokinase on malignant and unaffected adjacent human renal cellsJ C Kirchheimer, J Wojta, G Christ, et al.
Obstetrics and Gynecology|August 1, 1988
Increased plasma levels of urokinase-type plasminogen activator with endometrial and cervical cancerH Koelbl, J C Kirchheimer, G Tatra, et al.
Blood|November 15, 1996
Human fibroblasts downregulate plasminogen activator inhibitor type-1 in cultured human macrovascular and microvascular endothelial cellsJ C Zhang, A Fabry, L Paucz, et al.
The Journal of Biological Chemistry|February 5, 1991
Fibronectin decreases the stimulatory effect of fibrin and fibrinogen fragment FCB-2 on plasmin formation by tissue plasminogen activatorR Beckmann, M Geiger, C de Vries, et al.
Invasion & Metastasis|January 1, 1985
Plasminogen activator activity in bone metastases of prostatic carcinomas as compared to primary tumorsJ C Kirchheimer, H Pflüger, P Ritschl, et al.
Zeitschrift Fur Kardiologie|January 1, 1993
The role of type-1 plasminogen activator inhibitor in failure of thrombolytic therapy with recombinant tissue plasminogen activatorK Huber, R Beckmann, F Rauscha, et al.
Thrombosis Research|July 15, 1996
The ACE-inhibitor lisinopril affects plasma insulin levels but not fibrinolytic parametersM Zehetgruber, R Beckmann, H Gabriel, et al.
Thrombosis Research|June 1, 1992
Modulation of heparin cofactor II activity by glycosaminoglycans and adhesive glycoproteinsE Petzelbauer, D Seiffert, R Beckmann, et al.
Pageof 22